Search for Clinical Trial Results
Acinic Cell Carcinoma - 46 Studies Found
Status | Study |
Completed |
Study Name: Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine Condition:
|
Active, not recruiting |
Study Name: GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery Condition:
Interventions: |
Recruiting |
Study Name: Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer Condition:
|
Completed |
Study Name: CPI-613 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer Condition:
|
Active, not recruiting |
Study Name: Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients With Pancreatic Cancer Condition:
|
Suspended |
Study Name: Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery Condition:
|
Completed |
Study Name: Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine Hydrochloride Condition:
|
Completed |
Study Name: Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas Condition:
|
Completed |
Study Name: Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic Cancer Condition:
|
Recruiting |
Study Name: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Condition:
|